Keeper Security Expands Privileged Access Management Browser Isolation to Support Advanced Web Browsing Workflows
New capabilities remove usability barriers by enabling multi-tab browsing, secure file upload/download and KeeperAI threat detection within privileged vault sessions... Read more.
Keeper Security Expands Privileged Access Management Browser Isolation to Support Advanced Web Browsing Workflows
New capabilities remove usability barriers by enabling multi-tab browsing, secure file upload/download and KeeperAI threat detection within privileged vault sessions... Read more.
Keeper Security Expands Privileged Access Management Browser Isolation to Support Advanced Web Browsing Workflows
New capabilities remove usability barriers by enabling multi-tab browsing, secure file upload/download and KeeperAI threat detection within privileged vault sessions... Read more.
Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
APIA, Samoa, April 9, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, reported that crude oil perpetual futures volume on its TradFi platform surged... Read more.
Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
APIA, Samoa, April 9, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, reported that crude oil perpetual futures volume on its TradFi platform surged... Read more.
Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
APIA, Samoa, April 9, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, reported that crude oil perpetual futures volume on its TradFi platform surged... Read more.
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients Clinical trial designed to evaluate... Read more.
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients Clinical trial designed to evaluate... Read more.
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients Clinical trial designed to evaluate... Read more.
Halfpricesoft.com Enhances ezPaycheck with Built-In Payroll Accuracy Tools and e941 eFile Add-On
New features help employers stay compliant while simplifying tip income, overtime calculations, and quarterly tax filing REDMOND, Wash., April 9, 2026 /PRNewswire/... Read more.